These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25943000)

  • 21. Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population.
    Paolella D; Cherry E; Jolly JA; DeClercq J; Choi L; Zuckerman A
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1282-1288. PubMed ID: 31663457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
    Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
    Kale HP; Patel AM; Carroll NV
    J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up.
    Moczygemba LR; Barner JC; Lawson KA; Brown CM; Gabrillo ER; Godley P; Johnsrud M
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):328-38. PubMed ID: 21865093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.
    Dong X; Tsang CCS; Zhao S; Browning JA; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Hines LE; Wang J
    Curr Med Res Opin; 2021 Sep; 37(9):1581-1588. PubMed ID: 34039232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should eligibility for medication therapy management be based on drug adherence?
    Stuart B; Loh E; Miller L; Roberto P
    J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population.
    Musich S; Cheng Y; Wang SS; Hommer CE; Hawkins K; Yeh CS
    J Gen Intern Med; 2015 Aug; 30(8):1208-14. PubMed ID: 25666213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of provider mailings on medication adherence by Medicare Part D members.
    Borah BJ; Qiu Y; Shah ND; Gleason PP
    Healthc (Amst); 2016 Sep; 4(3):207-16. PubMed ID: 27637828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018.
    Li M; Bounthavong M
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1750-1756. PubMed ID: 34818087
    [No Abstract]   [Full Text] [Related]  

  • 30. Geographic variation in medication adherence in commercial and Medicare part D populations.
    Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T
    J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015.
    Chang TE; Ritchey MD; Park S; Chang A; Odom EC; Durthaler J; Jackson SL; Loustalot F
    Hypertension; 2019 Dec; 74(6):1324-1332. PubMed ID: 31679429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS; Gilmer T; Natarajan L; Hovell M
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a Combined Value-Based Insurance Design and Medication Therapy Management Program on Diabetes Medication Adherence.
    Peaslee A; Wickizer M; Olson J; Topp R
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1303-1309. PubMed ID: 27783550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing adherence and persistence across 6 chronic medication classes.
    Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
    J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
    Zhang L; Zakharyan A; Stockl KM; Harada AS; Curtis BS; Solow BK
    J Med Econ; 2011; 14(5):562-7. PubMed ID: 21728913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
    Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
    J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
    [No Abstract]   [Full Text] [Related]  

  • 38. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
    Almodóvar AS; Nahata MC
    J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
    Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
    J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcomes of a Medicare Part D telephone medication therapy management program.
    Moczygemba LR; Barner JC; Gabrillo ER
    J Am Pharm Assoc (2003); 2012; 52(6):e144-52. PubMed ID: 23229976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.